KALA BIO
KALA
11 hedge funds and large institutions have $369K invested in KALA BIO in 2026 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 3 closing their positions.
231% more capital inflows, than outflows
Capital inflows: $149K | Capital outflows: $45.1K
0.68% more ownership
Funds ownership: 3.77% → 4.45% (+0.68%)
8% less funds holding
Funds holding: 12 → 11 (-1)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$63.7K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$62.7K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$22.6K |
| 4 |
Morgan Stanley
New York
|
+$71 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$19.2K |
| 2 |
Goldman Sachs
New York
|
-$18.9K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$6.06K |
| 4 |
Barclays
London,
United Kingdom
|
-$472 |
| 5 |
Tower Research Capital (TRC)
New York
|
-$448 |
KALA Hedge Fund Activity: Q3 2026 in Review
11 of the 8,220 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q3 2026, worth a combined $369K — down 70% from $1.21M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of KALA and 2 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 2 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $63.7K. The largest seller was Qube Research & Technologies (QRT), exiting entirely with an estimated $19.2K sold.
- 11 institutional investors held KALA BIO (KALA) as of Q3 2026, down from 12 in Q2 2026.
- Funds reported $369K of KALA BIO stock for Q3 2026, down 70% quarter-over-quarter.
- 2 funds opened new KALA BIO positions in Q3 2026 and 3 closed out, a net change of -1 holder.
- The largest KALA BIO buyer in Q3 2026 was Renaissance Technologies, an estimated $63.7K added.
- The largest KALA BIO seller in Q3 2026 was Qube Research & Technologies (QRT), an estimated $19.2K sold.
Based on aggregated 13F filings for Q3 2026.